Companion Animals

Companion Cat CKD Advanced 2026

Advanced management of feline chronic kidney disease in 2026 includes new biomarkers, treatment options, and monitoring approaches.

Key Facts

SDMA (symmetric dimethylarginine) detects CKD earlier than creatinine, enabling earlier intervention
Anti-TGF-beta treatments are in clinical trials to reduce renal fibrosis progression
Phosphate binders have expanded in formulation making palatability management easier
Subcutaneous fluid therapy at home reduces clinic visits and stress for affected cats
Stage-based management guidelines provide clear frameworks for treatment decisions

Welfare Considerations

CKD management in 2026 benefits from earlier detection through SDMA monitoring, allowing intervention before significant loss of function causes welfare-impacting clinical signs. The goal of earlier detection is preventing the advanced uraemia, nausea, and weight loss that characterise late-stage CKD from developing before diagnosis. Each advance in detection and treatment represents fewer cats suffering the welfare costs of advanced kidney disease.

What You Can Do

Request SDMA testing alongside creatinine for cats over 7 years for earlier CKD detection
Discuss home subcutaneous fluid therapy with your vet for cats with moderate to advanced CKD
Monitor body weight and appetite weekly for cats with CKD to detect progression